It should be emphasized that an increased Th2 cell level was typical in severe COVID-19 [57], whereas the peak percentage of CXCR3–CCR6− Th2 cells was found in patients with unfavorable disease outcomes [92]. The gene discussed is CCR6; the disease is COVID-19.